On November 6, Philip Morris fell 3.06% in Pre-Market Trading, trading at $197.6295 per share, with turnover of $2.6626 million.
The move followed a recent market view that heavy investment behind ZYN is likely to pressure near-term profitability in the US business. The latest note indicated fourth-quarter selling, general and administrative expenses could rise about 10% sequentially, implying US operating companies income may fall to around break-even or slightly negative.
That concern has outweighed otherwise solid recent results. Philip Morris reported quarterly adjusted EPS of $2.36 on revenue of $11.44 billion, both above expectations, but previously lowered its adjusted EPS outlook to $8.11 to $8.26 from an earlier $8.35 to $8.50 range, reinforcing investor focus on margin pressure as elevated ZYN spending is expected to continue into next year.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments